Literature DB >> 7921749

Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis.

A K Jones1, V J Cunningham, S Ha-Kawa, T Fujiwara, S K Luthra, S Silva, S Derbyshire, T Jones.   

Abstract

A group of four patients with RA were examined to test the hypothesis that there is a change in the endogenous opioid system in the brain during inflammatory pain. Regional cerebral opioid receptor binding was quantified using the opioid receptor antagonist [11C] diprenorphine and positron emission tomography (PET). In the four patients studied in and out of pain, significant increases in [11C]diprenorphine binding were seen in association with a reduction in pain. Increases were seen in most of the areas of the brain that were sampled apart from the occipital cortex. Significant region-specific increases over and above the more generalized changes were also seen in the frontal, cingulate and temporal cortices in addition to the straight gyrus. These findings are consistent with the hypothesis that there are substantial increases in occupancy by endogenous opioid peptides during inflammatory pain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7921749     DOI: 10.1093/rheumatology/33.10.909

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  42 in total

Review 1.  Exploring the pain "neuromatrix".

Authors:  S W Derbyshire
Journal:  Curr Rev Pain       Date:  2000

2.  Alterations in endogenous opioid functional measures in chronic back pain.

Authors:  Ilkka K Martikainen; Marta Peciña; Tiffany M Love; Emily B Nuechterlein; Chelsea M Cummiford; Carmen R Green; Richard E Harris; Christian S Stohler; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 3.  Experimental designs and brain mapping approaches for studying the placebo analgesic effect.

Authors:  Luana Colloca; Fabrizio Benedetti; Carlo Adolfo Porro
Journal:  Eur J Appl Physiol       Date:  2007-10-25       Impact factor: 3.078

4.  Neuroimaging as a tool for pain diagnosis and analgesic development.

Authors:  Karolina Wartolowska; Irene Tracey
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 5.  Cerebral mechanisms operating in the presence and absence of inflammatory pain.

Authors:  A K Jones; S W Derbyshire
Journal:  Ann Rheum Dis       Date:  1996-07       Impact factor: 19.103

Review 6.  The role of positron emission tomography within the spectrum of medical imaging.

Authors:  T Jones
Journal:  Eur J Nucl Med       Date:  1996-02

Review 7.  Predictive mechanisms linking brain opioids to chronic pain vulnerability and resilience.

Authors:  Anthony Kenneth Peter Jones; Christopher Andrew Brown
Journal:  Br J Pharmacol       Date:  2017-06-10       Impact factor: 8.739

Review 8.  The use of functional neuroimaging to evaluate psychological and other non-pharmacological treatments for clinical pain.

Authors:  Karin B Jensen; Chantal Berna; Marco L Loggia; Ajay D Wasan; Robert R Edwards; Randy L Gollub
Journal:  Neurosci Lett       Date:  2012-03-14       Impact factor: 3.046

9.  A combined [11C]diprenorphine PET study and fMRI study of acupuncture analgesia.

Authors:  Darin D Dougherty; Jian Kong; Megan Webb; Ali A Bonab; Alan J Fischman; Randy L Gollub
Journal:  Behav Brain Res       Date:  2008-05-02       Impact factor: 3.332

Review 10.  Cognitive and emotional control of pain and its disruption in chronic pain.

Authors:  M Catherine Bushnell; Marta Ceko; Lucie A Low
Journal:  Nat Rev Neurosci       Date:  2013-05-30       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.